Intellipharmaceutics International Inc. (IPCI)

[fabius]

On Par website the following is shown in the home page
"Par Pharmaceutical is part of Endo International plc – a global specialty pharmaceutical company improving lives, creating value."

therefore the merger is now effective.

I couldn't find any evidence of Par still having an equity interest in IPCI; anyway 4% in 2007 should be less now (how many outstanding shares were in 2007 ?). If the partnership for the ANDAs still valid, then the time to market after approval should be fast.

From the last calculations and projections some of you posted in this board, I think that we can consider a conservative/realistic valutaion of 11.50-21 usd per share in 12 months from now, taking into account rexista and current 2 strenghts of focalin only and, if a I read correctly, wihout milestone and/or upfront payments (just royalties).